ELI LILLY AND COMPANY Earnings Per Share, Basic and Diluted
ELI LILLY AND COMPANY (LLY) reported Earnings Per Share, Basic and Diluted of $1.42 per share for the 3-month period ending 2013-03-31, per its 10-Q filed 2013-04-26.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2013-04-26
- ELI LILLY AND COMPANY earnings per share, basic and diluted for the quarter ending 2013-03-31 was $1.42, a 56.04% increase year-over-year.
- ELI LILLY AND COMPANY earnings per share, basic and diluted for the quarter ending 2012-09-30 was $1.18, a 6.31% increase year-over-year.
- ELI LILLY AND COMPANY earnings per share, basic and diluted for the quarter ending 2012-06-30 was $0.83, a 22.43% decline year-over-year.
- ELI LILLY AND COMPANY earnings per share, basic and diluted for the quarter ending 2012-03-31 was $0.91, a 4.21% decline year-over-year.
- ELI LILLY AND COMPANY earnings per share, basic and diluted for fiscal 2011 was $3.90, a 14.85% decline from fiscal 2010.
- ELI LILLY AND COMPANY earnings per share, basic and diluted for fiscal 2010 was $4.58, a 16.24% increase from fiscal 2009.
- ELI LILLY AND COMPANY earnings per share, basic and diluted for fiscal 2009 was $3.94.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 12 month |
|---|---|---|---|---|
| 2013-03-31 | $1.42 10-Q · filed 2013-04-26 | |||
| 2012-09-30 | $1.18 10-Q · filed 2012-10-26 | $2.92 10-Q · filed 2012-10-26 | ||
| 2012-06-30 | $0.83 10-Q · filed 2012-07-27 | $1.73 10-Q · filed 2012-07-27 | ||
| 2012-03-31 | $0.91 10-Q · filed 2013-04-26 | |||
| 2011-12-31 | $3.90 10-K · filed 2012-02-24 | |||
| 2011-09-30 | $1.11 10-Q · filed 2012-10-26 | $3.13 10-Q · filed 2012-10-26 | ||
| 2011-06-30 | $1.07 10-Q · filed 2012-07-27 | $2.02 10-Q · filed 2012-07-27 | ||
| 2011-03-31 | $0.95 10-Q · filed 2012-04-30 | |||
| 2010-12-31 | $4.58 10-K · filed 2012-02-24 | |||
| 2010-09-30 | $1.18 10-Q · filed 2011-10-28 | $3.53 10-Q · filed 2011-10-28 | ||
| 2010-06-30 | $1.22 10-Q · filed 2011-07-29 | $2.35 10-Q · filed 2011-07-29 | ||
| 2010-03-31 | $1.13 10-Q · filed 2011-04-29 | |||
| 2009-12-31 | $3.94 10-K · filed 2012-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Akari Therapeutics Plc (AKTX) | $1,527.991B | -47,921.42 | |
| JOHNSON & JOHNSON (JNJ) | United States | $652.528B | 29.10 |
| AbbVie Inc. (ABBV) | United States | $468.180B | 70.37 |
| Merck & Co., Inc. (MRK) | United States | $365.215B | 99.96 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |